Education
Baghdad Teaching Hospital field record: a multidisciplinary Carvedilol teaching session
Dr. Farouq Hameed, Clinical Cardiology Fellow, led a Baghdad Teaching Hospital session on indication-specific Carvedilol use and clinical stability, supervised by Prof. Hasan Ali Farhan and attended by fellows across four cardiovascular disciplines.
- Prepared by
- Iraq Cardiology Editorial Team
- Source authors
- Dr. Farouq Hameed, Clinical Cardiology Fellow
- Last reviewed
- August 23, 2026
- Reading time
- 4 min

Quick summary
The essential point, in one sentence.
Reading companion
A professional question, bounded to this record.
Answers use this update and its recorded sources only; it does not provide individual treatment advice.
Today’s activity
At Baghdad Teaching Hospital, Baghdad Center of Cardiology, Dr. Farouq Hameed, Clinical Cardiology Fellow, delivered a teaching session on Carvedilol and the importance of matching beta-blocker decisions to the clinical indication and the patient’s stability. The activity was supervised by Prof. Hasan Ali Farhan.
Clinical Cardiology, Clinical Pharmacy, Cardiac Imaging, and Interventional Cardiology fellows attended the session, creating a focused multidisciplinary discussion around practical cardiovascular pharmacotherapy.
Learning focus
The supplied teaching material used case-based discussion to examine Carvedilol pharmacology, evidence-based beta-blocker selection in HFrEF, indication-specific initiation and follow-up, tolerance assessment, and clinically relevant interactions.
The session emphasized that a medication plan should be interpreted within the patient’s physiology, current stability, and the wider treatment regimen—not as a generic dosing exercise.
Clinical boundary
This field record documents an educational activity. It does not reproduce a prescribing protocol or provide patient-specific treatment advice. Clinical decisions should remain aligned with current guidance, local protocols, product information, and individual patient assessment.
Editorial record
This report is based on the supplied teaching deck and activity information. The photograph was authorized for publication by the contributor.
Source
Carvedilol teaching deck presented at Baghdad Teaching Hospital, Baghdad Center of Cardiology, 23 August 2026.
Professional discussion starter
Turn reading into a balanced conversation.
Prompts for professional reflection—not individual treatment advice.
- 1Which element of the source most changes how your team would frame Carvedilol in HFrEF and hypertension?
- 2Which limitation or context should be made explicit before discussing application?
- 3What question is worth taking to a journal club or multidisciplinary meeting?
Continue reading
Related updates
Education
HFpEF in 2026: diagnose the syndrome, search for mimics, treat the whole phenotype
A 2026 ACC expert pathway frames HFpEF as a multisystem syndrome: diagnose thoughtfully, look for cardiac and noncardiac mimics, and address comorbidities alongside evidence-based therapy.
Read updateEducation
Subclinical Coronary Atherosclerosis and Myocardial Infarction Risk: Evidence From a Danish CT Cohort
A Danish population cohort found less subclinical coronary atherosclerosis in women, while obstructive disease on CT was associated with higher myocardial infarction risk in both women and men.
Read update